| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1286 | 2020 |
| Human monocyte subsets and phenotypes in major chronic inflammatory diseases TS Kapellos, L Bonaguro, I Gemünd, N Reusch, A Saglam, ER Hinkley, ... Frontiers in immunology 10, 2035, 2019 | 747 | 2019 |
| Swarm learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature 594 (7862), 265-270, 2021 | 588 | 2021 |
| Neutrophils in COVID-19 N Reusch, E De Domenico, L Bonaguro, J Schulte-Schrepping, K Baßler, ... Frontiers in immunology 12, 652470, 2021 | 285 | 2021 |
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients AC Aschenbrenner, M Mouktaroudi, B Krämer, M Oestreich, N Antonakos, ... Genome medicine 13, 1-25, 2021 | 236 | 2021 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 177 | 2021 |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19 P Georg, R Astaburuaga-García, L Bonaguro, S Brumhard, L Michalick, ... Cell 185 (3), 493-512. e25, 2022 | 155 | 2022 |
| A guide to systems-level immunomics L Bonaguro, J Schulte-Schrepping, T Ulas, AC Aschenbrenner, M Beyer, ... Nature immunology 23 (10), 1412-1423, 2022 | 48 | 2022 |
| Suppressive myeloid cells are a hallmark of severe COVID-19 J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... MedRxiv, 2020.06. 03.20119818, 2020 | 29 | 2020 |
| Creld2 function during unfolded protein response is essential for liver metabolism homeostasis P Kern, NR Balzer, F Bender, A Frolov, K Wunderling, JP Sowa, ... bioRxiv, 2020.01. 28.923136, 2020 | 23 | 2020 |
| CRELD1 modulates homeostasis of the immune system in mice and humans L Bonaguro, M Köhne, L Schmidleithner, J Schulte-Schrepping, ... Nature Immunology 21 (12), 1517-1527, 2020 | 17 | 2020 |
| Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation K Baßler, W Fujii, TS Kapellos, E Dudkin, N Reusch, A Horne, B Reiz, ... Frontiers in immunology 13, 917232, 2022 | 15 | 2022 |
| Alterations of multiple alveolar macrophage states in chronic obstructive pulmonary disease K Baßler, W Fujii, TS Kapellos, A Horne, B Reiz, E Dudkin, M Lücken, ... BioRxiv, 2020.05. 28.121541, 2020 | 15 | 2020 |
| Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19 E De Domenico, L Bonaguro, J Schulte-Schrepping, M Becker, K Händler, ... STAR protocols 1 (3), 100233, 2020 | 13 | 2020 |
| Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019; 10: 2035 TS Kapellos, L Bonaguro, I Gemünd, N Reusch, A Saglam, ER Hinkley, ... Epub 2019/09/24. https://doi. org/10.3389/fimmu. 2019.02035 PMID: 31543877, 2019 | 12 | 2019 |
| Creld1 regulates myocardial development and function V Beckert, S Rassmann, AH Kayvanjoo, C Klausen, L Bonaguro, ... Journal of Molecular and Cellular Cardiology 156, 45-56, 2021 | 10 | 2021 |
| Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease TS Kapellos, K Baßler, W Fujii, C Nalkurthi, AC Schaar, L Bonaguro, ... Cell reports 42 (6), 2023 | 8 | 2023 |
| Induction of Rosette-to-Lumen stage embryoids using reprogramming paradigms in ESCs J Langkabel, A Horne, L Bonaguro, L Holsten, T Hesse, A Knaus, ... Nature Communications 12 (1), 7322, 2021 | 8 | 2021 |
| Lung T cell response in COVID-19 MH Shakiba, I Gemünd, M Beyer, L Bonaguro Frontiers in Immunology 14, 1108716, 2023 | 5 | 2023 |
| Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state C Carraro, L Bonaguro, J Schulte-Schrepping, A Horne, M Oestreich, ... Elife 11, e78012, 2022 | 5 | 2022 |
